openPR Logo

Press Releases from Berlin Heart (20 total)

The 1,500th child supported by the Berlin Heart ventricular assist device has be …

The EXCOR® Pediatric ventricular assist device (VAD) has been implanted in more than 1,500 children worldwide to save their lives. In June 2014 for the 1,500th time, the EXCOR® Pediatric device was implanted to save the life of a child: a 14-year-old boy from Hong Kong who was suffering from dilated cardiomyopathy since the age of four was supported with the life-saving device. Up to that point the teenager had

100th EXCOR® Implantation in Spain

In March 2015 the clinic La Paz Madrid recorded a particular success: After ten years of EXCOR® therapy in Spain, the 100th implantation of the Berlin Heart was performed. La Paz is one of the leading Spanish hospitals for pediatric heart surgery. Almost simultaneously in another clinic in Madrid the 101st implantation took place and further implantations followed. The clinics in Spain benefit from an excellent service by Palex Medical

Regensburg patient for five years on a ventricular assist device

It was a special anniversary for Mr. Max. K from the Bavarian town Ortenburg: For five years now he is kept alive by the ventricular assist device (VAD) INCOR®. Within the University Hospital Regensburg Mr. K is the patient with the longest support time by this device. The patient’s story of the 54-year-old patient goes back a few years. After he had a strong flu in 2006, Max K.’s right heart

Berlin Heart employees cook for families at the Ronald McDonald house

In the afternoon of July, 31st 2014 ten Berlin Heart employees gathered at the Ronald McDonald House in Berlin-Wedding to prepare a three-course-menu for the residents. That night mache with chanterelle and caramelized walnuts followed by coq au vin and a peach and raspberry crumble with pistachios and vanilla ice cream as desert were on the menu. The aim of the volunteers was not only to serve a delicious dinner

Longest support time with the EXCOR® Pediatric ventricular assist device

Six year old Lara from Erlangen is the toddler with the longest support time of a ventricular assist device (VAD) in the world. The small patient was treated an entire 877 days with the VAD EXCOR® Pediatric in the University Hospital in Erlangen and, thanks to this therapy, could recover so well that she was now able to receive a new heart a few days ago. In February 2010 Lara was in

Five-year-old Berlin Heart patient included in photography artist Horst Wackerba …

Horst Wackerbarth, a worldwide famous photography artist is travelling around Europe with his red couch in order to take pictures of people of various cultures. For the first time he recently took his couch to Bad Oeynhausen where Dr. Eugen Sandica, chief surgeon at the Heart and Diabetes Center Bad Oeynhausen, and his young heart failure patient Tobias sat down. For five-year-old Tobias, the photo-shooting with Horst Wackerbarth was a most

1000th child to be supported with the Berlin Heart ventricular assist device

Berlin, 24th January 2012: The EXCOR® Pediatric ventricular assist device has been implanted in more than 1000 cases. This so-called artificial heart enables seriously ill children with heart defects to bridge the time until a suitable donor heart is found. It is the only system worldwide that is designed especially for the physiological needs of children. This system was invented in Berlin and is used in children of all ages all

Robert Kroslowitz appointed President and CEO Berlin Heart Inc.

Berlin Heart GmbH announced that Robert Kroslowitz, Vice President Clinical Affairs at Berlin Heart Inc. in The Woodlands, Texas, has been appointed President and CEO of the company’s North American Operations. Robert Kroslowitz joined Berlin Heart in December 2005. Prior to joining Berlin Heart, Robert was employed as Director of Clinical Operations and head of other established corporations. He also possesses longstanding clinical and research experience in the cardiovascular space having

Berlin´s Medical-Technical Companies: Permanent Secretary Almuth Hartwig-Tiedt …

Berlin, 12 September 2011: The Permanent Secretary for Economics, Technology and Women’s Issues, Almuth Hartwig-Tiedt visited Berlin Heart a few days ago, as part of an information tour regarding the current situation of Berlin´s Med-Tech companies – and particularly, the ventricular (heart) assist device market. Together with the General Management of Berlin Heart, latest therapy options with heart-assist devices were discussed. As Berlin Heart´s EXCOR® Pediatric device for children is unique

Berlin Heart Centers 2011: Number of worldwide clinics implanting Berlin Heart v …

Berlin, 29 July 2011: The increasing number of heart centers working with Berlin Heart ventricular assist devices is an indicator for the Berlin-based company that these devices are urgently needed by patients suffering from heart failure. Not only German clinics, as for example the University Hospital Aachen, but also international hospitals such as the University Hospital Nantes, France, the Instituto Nacional de Cardiologia in Rio de Janeiro, Brazil and the

FDA Advisory Panel Unanimously Recommends Approval of EXCOR Pediatric Ventricula …

Berlin Germany, The Woodlands Texas, Tuesday July 26, 2011 At the request of Dr. Bram Zuckerman, Director, Division of Cardiovascular Devices, Center for Devices and Radiologic Health of the United States Food and Drug Administration, a special panel was convened on Thursday July 21 in Gaithersburg, Maryland to review the results of the EXCOR® IDE clinical trial. The specific charge of the panel was to review the clinical data from

Hope for a new possibility of therapy for children suffering from heart insuffic …

Newborns with heart failure or children suffering from severe heart insufficiency in Poland don’t really have much of a choice. A heart transplant most of the time is the only survival possibility. The problem the Polish doctors are facing, is that there is hardly a chance to keep their patient’s condition stable until heart transplant becomes possible. Waiting times are much too long until donor hearts become available. The demand

Major Milestone Achieved – EXCOR® Pediatric HDE Application Under Review

The Berlin Heart Group reported today that the results of the US IDE Trial for the Berlin Heart EXCOR® Pediatric Ventricular Assist Device have been submitted to the FDA in an HDE application. The FDA has informed the company that the application is officially under review and that a tentative panel date has been scheduled. The study, which enrolled the first patient in November 2007, is the first prospective clinical

Swedish clinics achieve excellent outcome with EXCOR® assist device program

It is only three years ago, when the Sahlgrenska University Hospital and the Queen Silvia Children Hospital in Sweden started to implant the EXCOR® ventricular assist device (VAD) to patients suffering from severe heart failure. In the event of the own heart no longer being able to provide the vital pump function of pumping blood through the body, the device offers a life-saving therapy for patients of every age and

Berlin Heart engineer receives Joachim-Jungius-Award of Rostock University

Berlin, 22 November 2010. Dr. Andreas Arndt, a team leader at Berlin Heart has just received the Joachim-Jungius-award of Rostock University for his outstanding research work on the field of implantable heart assist devices. In the context of his thesis, Dr. Arndt developed a fully automatic, physiological regulation of the blood flow for the currently available implantable assist device INCOR®. Thus, the flow of blood is able to adapt perfectly

800 “EXCOR® Pediatric” implants worldwide: The life-saving ventricular assi …

Berlin, Germany. 29 October 2010. This month, the 800th Berlin Heart EXCOR® Pediatric ventricular assist device was implanted in a child suffering from severe heart failure. For the pediatric population with severe heart failure, whose hearts do not provide them with the necessary pump function; mechanical circulatory support with the Berlin Heart device can provide life-saving therapy while these little patients desperately await heart transplantation. The device is unique worldwide,

INCOR® Ventricular Assist Device improval through new features – so far more …

Berlin, 22 October 2010. Since the device improval through additional features and innovative software settings, more than 50 INCOR® ventricular assist devices have been implanted in patients suffering from severe heart failure. The new textured inflow cannula tip improves the myocardial ingrowth in the heart and the intelligent software settings, which on one hand produces an effective wash-out of the left ventricle and on the other, promotes aortic valve

Major Milestone Achieved – EXCOR® Pediatric IDE Trial Enrolment Complete

Berlin, 13 September 2010: The Berlin Heart Group reported today that enrolment in the US IDE Trial of the Berlin Heart EXCOR® Pediatric Ventricular Assist Device is now complete at 48 patients. The first patient was enrolled in November 2007, and thus full enrolment of the trial took approximately thirty-three months. The National Principal Investigator, Charles D. Fraser, Jr., M.D., Surgeon-In-Chief and Head of the Division of Congenital Heart Surgery at

Taiwan relies on ventricular assist devices made in Berlin

Berlin, 1st of September 2010. The demand for donor hearts in Taiwan is rising continuously, however the availability of such donor organs is quite insufficient. Helping these severely ill patients, medical centers like the National Taiwan University Hospital, the Taiwan Veterans General Hospital Taipeh and the Chang Gung Memorial Hospital increasingly focus on so called ventricular assist devices (VAD) from the German company Berlin Heart. The implantable INCOR® as well

Hope for children suffering from heart failure in Japan: University of Tokyo Hos …

Berlin, 30th of July 2010. Donor organs in Japan are rare, waiting times until a donor heart becomes available are quite long. Especially children, who from now on can receive donor organs due to recent law changes, are affected from long waiting times. Therefore Prof. Kyo – professor and chief of the Department for Therapeutic Strategy for Heart Failure at the University of Tokyo Hospital - plans to establish

Go To Page:   0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 -19 -18 -17 -16 -15 -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1